An artist's rendering shows how a new pacemaker, designed by a UArizona-led team of researchers, is able to envelop the heart. The wireless, battery-free pacemaker could be implanted with a less invasive procedure than currently possible and would cause patients less pain. Illustration credit: Philipp Gutruff
October 31, 2022
Battery-Free, Light-Powered Pacemaker May Improve Quality of Life for Heart Disease Patients
October 31, 2022 —  Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000…
Read More
Patent builds on previously granted U.S. patent as well as strengthens and diversifies the IP portfolio and further protects future revenues
October 28, 2022
HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista ECG
October 28, 2022 —  Heart Test Laboratories, Inc., a medical technology company focused on saving lives by making an…
Read More
The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure
October 28, 2022
V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure
October 28, 2022 —  V-Wave, announced today the completion of enrollment in RELIEVE-HF, a prospective, randomized,…
Read More
SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational Device Exemption (IDE) approval to initiate its coronary pivotal clinical trial.
October 28, 2022
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
October 28, 2022 —  SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received FDA Investigational…
Read More
Elite young athletes are set to benefit from a novel screening tool with the potential to change clinical practice by ruling out a serious heart condition frequently misdiagnosed. #GabeMillane #Batavia #BataviaBulldogs #BataviaFootball
October 27, 2022
Rising Star Footballers Among Young Athletes to Benefit From New Screening Tool
October 27, 2022 —  Elite young athletes are set to benefit from a novel screening tool with the potential to change…
Read More
Barostim Baroreflex Activation Therapy is the world’s first FDA-approved device which uses the power of the brain and nervous system to improve symptoms of progressive heart failure
October 27, 2022
Allegheny Health Network Cardiovascular Institute First in Pittsburgh to Implant Groundbreaking Neuromodulation Device as Alternative Therapy for Heart Failure Patients
October 27, 2022 —  Vascular surgeons from Allegheny General Hospital (AGH) Cardiovascular Institute, the flagship…
Read More
The research team members say they have long known that infections such as the flu can increase risk for heart disease and heart attack, but the sharp rise in heart attack deaths is like nothing seen before.
October 27, 2022
COVID-19 Surges Linked to Spike in Heart Attacks
October 27, 2022 —  New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart…
Read More
Clinical study evaluates treatment for endovascular aortic arch repair
October 26, 2022
UH Harrington Heart and Vascular Institute Performs First TRIOMPHE Study Case in Northeast Ohio
October 26, 2022 —  Thousands of people have new hope for treatment of thoracic aortic arch disease and University…
Read More
Alex Carll, assistant professor in the UofL Department of Physiology, front, with Matthew Nystoriak, associate professor of medicine. (UofL Photo)
October 26, 2022
UofL Researchers Discover E-Cigarettes Cause Cardiac Arrhythmias
October 26, 2022 —  A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute…
Read More
Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support
October 26, 2022
Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare
October 26, 2022 —   Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved…
Read More
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
October 25, 2022
RhythMedix Expands Monitoring Capabilities of Its RhythmStar System, the First Wearable Cardiac Monitor with Built-In Cellular Connectivity
October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms,…
Read More
Asher Kimchi, MD: 1946-2022
October 24, 2022
Founder, Medical Co-Director of Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute Remembered
October 24, 2022 — Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine,…
Read More
CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.
October 24, 2022
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly…
Read More
Donald Baril, MD, a Leading Vascular Surgeon in the Smidt Heart Institute, Named Director of the Vascular Surgery Fellowship Program
October 24, 2022
Vascular Surgeon to Lead, Train Fellows
October 24, 2022 The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as…
Read More
Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated announced submission of pivotal clinical data from the AcQForce Flutter trial
October 24, 2022
Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter and System
October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac…
Read More
Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.
October 21, 2022
Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure
October 21, 2022 —  Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-…
Read More
Medtronic “Conduction System Pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates
October 21, 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
October 21, 2022 —  Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food…
Read More
A composite photo demonstrating how mixed reality visualization would be combined with robotic surgery in an MRI.
October 20, 2022
Mixed-Reality Robotic Heart Surgery Inside an MRI?
October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National…
Read More
The American Heart Association to enable a wide range of research with real-time data from acute care hospitals
October 20, 2022
New Data Registry Collects Evidence in Cardiogenic Shock Patients
October 20, 2022 — Cardiogenic shock—a life threatening condition when a person’s heart can’t pump enough blood to meet…
Read More
MedAtlas CV will transform cardiovascular care delivery and expand patient access
October 20, 2022
Atlas Healthcare Partners and MedAxiom Unveil Cardiovascular ASC Solution, MedAtlas CV
October 20, 2022 — Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now